Evidence map›Paper›PMID 34503503›Full record

ArticleBMC health services research2021

Geospatial analysis and impact of targeted development of breast cancer care in The Gambia: a cross-sectional study.

Ousman Sanyang, Fidel Lopez-Verdugo, Meghan Mali, Moustafa Moustafa, Jonathan Nellermoe, Justin Sorensen, Mustapha Bittaye, Ramou Njie, Yankuba Singhateh, Ngally Aboubacarr Sambou and 5 more

Abstract read
In one paragraph

Article in BMC health services research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ousman Sanyang *Center for Global Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.
Fidel Lopez-Verdugo *Center for Global Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.
Meghan Mali *Center for Global Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.
Moustafa MoustafaCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.
Jonathan NellermoeCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.
Justin SorensenJ. Willard Marriott Library, University of Utah, Salt Lake City, UT, USA.
Mustapha BittayeSchool of Medicine and Allied Health Sciences, University of The Gambia, Banjul, The Gambia.
Ramou NjieDepartment of Surgery, Edward Francis Small Teaching Hospital, Banjul, The Gambia.
Yankuba SinghatehThe Gambia Ministry of Health, Banjul, The Gambia.
Ngally Aboubacarr SambouThe Gambia Ministry of Health, Banjul, The Gambia.
Alison GoldsmithCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.
Nuredin I MohammedMedical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
Kirstyn E BrownsonCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.
Raymond R PriceCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA.
Edward SutherlandCenter for Global Surgery, University of Utah School of Medicine, Salt Lake City, UT, USA. sutherlandmd@yahoo.com.

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Medical Research Council MR/R010161/1NCATS NIH HHS UL1 TR002538
6 · The paper itself

Abstract

backgroundThe Gambia has one of the lowest survival rates for breast cancer in Africa. Contributing factors are late presentation, delays within the healthcare system, and decreased availability of resources. We aimed to characterize the capacity and geographic location of healthcare facilities in the country and calculate the proportion of the population with access to breast cancer care.

methodsA facility-based assessment tool was administered to secondary and tertiary healthcare facilities and private medical centers and clinics in The Gambia. GPS coordinates were obtained, and proximity of service availability and population analysis were performed. Distance thresholds of 10, 20, and 45 km were chosen to determine access to screening, pathologic diagnosis, and surgical management. An additional population analysis was performed to observe the potential impact of targeted development of resources for breast cancer care.

resultsAll 102 secondary and tertiary healthcare facilities and private medical centers and clinics in The Gambia were included. Breast cancer screening is mainly performed through clinical breast examination and is available in 52 facilities. Seven facilities provide pathologic diagnosis and surgical management of breast cancer. The proportion of the Gambian population with access to screening, pathologic diagnosis, and surgical management is 72, 53, and 62%, respectively. A hypothetical targeted expansion of resources would increase the covered population to 95, 62, and 84%.

conclusionsAlmost half of the Gambian population does not have access to pathologic diagnosis and surgical management of breast cancer within the distance threshold utilized in the study. Mapping and population analysis can identify areas for targeted development of resources to increase access to breast cancer care.

Indexed as

Breast NeoplasmsCross-Sectional StudiesEarly Detection of CancerFemaleGambiaHealth Services AccessibilityHumansMass ScreeningAccess to cancer careBreast cancerGeospatial analysisGlobal healthGlobal surgerySub-Saharan Africa

Identifiers

PMID34503503
PMCPMC8428029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.